Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2-4 year olds generated a weaker immune response than expected, potentially delaying authorization. The company said it is testing a three-dose course of the vaccine in all age groups under 16, including 2-4 year olds.
Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization.
Pfizer says 2021 COVID-19 vaccine sales to top $33 5 bln, sees need for boosters bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.
Pfizer says 2021 COVID-19 vaccine sales to top $33 5 billion, sees need for boosters netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.